Palmitoylethanolamide stimulates phagocytosis of Escherichia coli K1 and Streptococcus pneumoniae R6 by microglial cells

Journal of Neuroimmunology

Volumn 244, Issue 1-2, 2012, Pages 32-34

  Redlich, Sandra ^a,b   Ribes, Sandra ^a   Schütze, Sandra ^a   Czesnik, Dirk ^a   Nau, Roland ^a,c  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

^c Sleep Laboratory   (Germany)

Author keywords

Cannabinoid receptor; Meningitis; Microglia; Palmitoylethanolamide

Indexed keywords

ESCHERICHIA COLI LIPOPOLYSACCHARIDE; PALMIDROL;

ANIMAL CELL; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; ESCHERICHIA COLI; ESCHERICHIA COLI K1; IN VITRO STUDY; INFECTION RESISTANCE; MICROGLIA; MOUSE; NERVE CELL STIMULATION; NEWBORN; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIAE;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CELLS, CULTURED; ESCHERICHIA COLI; MICE; MICE, INBRED C57BL; MICROGLIA; PALMITIC ACIDS; PHAGOCYTOSIS; STREPTOCOCCUS PNEUMONIAE;

EID: 84857910035     PISSN: 01655728     EISSN: 18728421     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2011.12.013     Document Type: Article

References (18)

1. Baker D., Pryce G., Croxford J.L., Brown P., Pertwee R.G., Huffman J.W., Layward L. Cannabinoids control spasticity and tremor in a multiple sclerosis model. Nature 2000, 404(6773):84-87. available from: PM:10716447.
2. Baker D., Pryce G., Croxford J.L., Brown P., Pertwee R.G., Makriyannis A., Khanolkar A., Layward L., Fezza F., Bisogno T., Di M.V. Endocannabinoids control spasticity in a multiple sclerosis model. FASEB J. 2001, 15(2):300-302. available from: PM:11156943.
3. Calignano A., La R.G., Giuffrida A., Piomelli D. Control of pain initiation by endogenous cannabinoids. Nature 1998, 394(6690):277-281. available from: PM:9685157.
4. Calignano A., La R.G., Piomelli D. Antinociceptive activity of the endogenous fatty acid amide, palmitylethanolamide. Eur. J. Pharmacol. 2001, 419(2-3):191-198. available from: PM:11426841.
5. Conti S., Costa B., Colleoni M., Parolaro D., Giagnoni G. Antiinflammatory action of endocannabinoid palmitoylethanolamide and the synthetic cannabinoid nabilone in a model of acute inflammation in the rat. Br. J. Pharmacol. 2002, 135(1):181-187. available from: PM:11786493.
6. Cravatt B.F., Giang D.K., Mayfield S.P., Boger D.L., Lerner R.A., Gilula N.B. Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides. Nature 1996, 384(6604):83-87. available from: PM:8900284.
7. Cravatt B.F., Saghatelian A., Hawkins E.G., Clement A.B., Bracey M.H., Lichtman A.H. Functional disassociation of the central and peripheral fatty acid amide signaling systems. Proc. Natl. Acad. Sci. U.S.A. 2004, 101(29):10821-10826. available from: PM:15247426.
8. De P.L., Davis J.B., Di M.V. Palmitoylethanolamide enhances anandamide stimulation of human vanilloid VR1 receptors. FEBS Lett. 2001, 506(3):253-256. available from: PM:11602256.
9. Franklin A., Parmentier-Batteur S., Walter L., Greenberg D.A., Stella N. Palmitoylethanolamide increases after focal cerebral ischemia and potentiates microglial cell motility. J. Neurosci. 2003, 23(21):7767-7775. available from: PM:12944505.
10. Lambert D.M., Vandevoorde S., Diependaele G., Govaerts S.J., Robert A.R. Anticonvulsant activity of N-palmitoylethanolamide, a putative endocannabinoid, in mice. Epilepsia 2001, 42(3):321-327. available from: PM:11442148.
11. Lambert D.M., Vandevoorde S., Jonsson K.O., Fowler C.J. The palmitoylethanolamide family: a new class of anti-inflammatory agents?. Curr. Med. Chem. 2002, 9(6):663-674. available from: PM:11945130.
12. Lo V.J., Fu J., Astarita G., La R.G., Russo R., Calignano A., Piomelli D. The nuclear receptor peroxisome proliferator-activated receptor-alpha mediates the anti-inflammatory actions of palmitoylethanolamide. Mol. Pharmacol. 2005, 67(1):15-19. available from: PM:15465922.
13. Loverme J., Russo R., La R.G., Fu J., Farthing J., Mattace-Raso G., Meli R., Hohmann A., Calignano A., Piomelli D. Rapid broad-spectrum analgesia through activation of peroxisome proliferator-activated receptor-alpha. J. Pharmacol. Exp. Ther. 2006, 319(3):1051-1061. available from: PM:16997973.
14. Muccioli G.G., Stella N. Microglia produce and hydrolyze palmitoylethanolamide. Neuropharmacology 2008, 54(1):16-22. available from: PM:17631917.
15. Nau R., Bruck W. Neuronal injury in bacterial meningitis: mechanisms and implications for therapy. Trends Neurosci. 2002, 25(1):38-45. available from: PM:11801337.
16. Tsuboi K., Takezaki N., Ueda N. The N-acylethanolamine-hydrolyzing acid amidase (NAAA). Chem. Biodivers. 2007, 4(8):1914-1925. available from: PM:17712833.
17. Ueda N., Kurahashi Y., Yamamoto S., Tokunaga T. Partial purification and characterization of the porcine brain enzyme hydrolyzing and synthesizing anandamide. J. Biol. Chem. 1995, 270(40):23823-23827. available from: PM:7559559.
18. Xie Y., Kim K.J., Kim K.S. Current concepts on Escherichia coli K1 translocation of the blood-brain barrier. FEMS Immunol. Med. Microbiol. 2004, 42(3):271-279. available from: PM:15477040.